Early onset of efficacy with fremanezumab in patients with episodic and chronic migraine: subanalysis of two phase 2b/3 trials in Japanese and Korean patients

BACKGROUND: Early onset of action has become recognized as an important efficacy feature of preventive migraine treatment, which can help overcome adherence issues commonly associated with older medications. Preventive treatments that target the calcitonin gene-related peptide (CGRP) or the CGRP rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeshima, Takao, Nakai, Masami, Shibasaki, Yoshiyuki, Ishida, Miki, Kim, Byung-Kun, Ning, Xiaoping, Koga, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903536/
https://www.ncbi.nlm.nih.gov/pubmed/35139816
http://dx.doi.org/10.1186/s10194-022-01393-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903536/
https://www.ncbi.nlm.nih.gov/pubmed/35139816
http://dx.doi.org/10.1186/s10194-022-01393-0

Ejemplares similares